CTx-TFEB

N/A

Report date: 2024/11/12 16:48:32

Base Information

Drug NameCTx-TFEB
Drug Alias NameCTx-TFEB
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSynuclein alpha modulatorsTranscription factor EB stimulants
TargetsSynuclein alphaTranscription factor EB
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoave Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesCoave Therapeutics SA
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A